Quick Answer
Tempest Therapeutics, Inc. reported Common Stock Shares Outstanding of 4.93 million shares for the year ending 2025.
- Tempest Therapeutics, Inc. showed an increase of +45.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Tempest Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), Tempest Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 307.3%.
- Historical annual values: Fiscal year 2025: 4.93 million shares | Fiscal year 2024: 3.38 million shares | Fiscal year 2023: 22.05 million shares | Fiscal year 2022: 10.52 million shares | Fiscal year 2021: 6.91 million shares | Fiscal year 2020: 19.00 million shares | Fiscal year 2019: 18.27 million shares | Fiscal year 2018: 13.36 million shares | Fiscal year 2017: 246,347 shares | Fiscal year 2016: 35.64 million shares | Fiscal year 2015: 27.30 million shares | Fiscal year 2014: 24.08 million shares | Fiscal year 2013: 17.54 million shares | Fiscal year 2012: 12.62 million shares | Fiscal year 2011: 1.21 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: